Sore throat

argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia

Retrieved on: 
Tuesday, March 26, 2024
Diagnosis, Blood pressure, Efgartigimod alfa, System, Urination, Urinary tract infection, MHLW, Chest pain, Rituximab, Allergy, Disease, Infection, Risk, Headache, Patient, Sore throat, IWG, History, ITP, Chills, Quality of life, Cough, Euronext, Rash, Respiratory tract infection, Splenectomy, Medicine, Skin, Fever, Antibody, Wheeze, Back pain, Shivering, Safety, Pain, Fatigue, Phlegm, Swelling, Food, Autoimmune disease, Nursing

“argenx is on a mission to deliver transformative medicines for people living with severe autoimmune disease,” said Tim Van Hauwermeiren, Chief Executive Officer of argenx.

Key Points: 
  • “argenx is on a mission to deliver transformative medicines for people living with severe autoimmune disease,” said Tim Van Hauwermeiren, Chief Executive Officer of argenx.
  • By reducing circulating autoantibodies, VYVGART is uniquely designed to serve as a precision intervention that targets the underlying disease biology of ITP.
  • ADVANCE successfully met its primary endpoint, demonstrating that a higher proportion of chronic ITP patients receiving VYVGART achieved a sustained platelet count response compared to placebo.
  • Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART.

Olympus Partners with American Lung Association on Patient Education for Lung Cancer Screening

Retrieved on: 
Wednesday, March 27, 2024
Diagnosis, Biopsy, Lung cancer, Medicine, Immunotherapy, Disease, Infection, Partnership, Patient, Sore throat, Perforation, Cancer, United, Olympus Corporation, Senior, Lymph, Bleeding, EUS, American Lung Association, Physician, Medical imaging

CENTER VALLEY, Pa., March 27, 2024 /PRNewswire/ -- Olympus Corporation of the Americas, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, is now partnering with the American Lung Association to educate lung cancer patients about the care pathway for diagnosing and staging lung nodules.

Key Points: 
  • The lung nodules educational resources , sponsored by Olympus, help patients understand the diagnosis and staging process for lung nodules and why it is important to their treatment journey.
  • "Olympus is very excited to support this great new educational resource for lung cancer patients through our partnership with the American Lung Association," said Jovan Reyerson, Senior Vice President of Medical and Scientific Affairs at Olympus Corporation of the Americas.
  • Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), a procedure pioneered by Olympus, has helped lay the groundwork for targeted cancer treatment such as immunotherapy.
  • Lung cancer remains the leading cause of cancer death in the United States.² Early detection of lung cancer is key as the 5-year relative survival rate for non-small cell lung cancer is about 65% when caught at a localized stage.

ColdZyme® certified under the new EU medical device regulation (MDR)

Retrieved on: 
Monday, March 11, 2024
Certification, Infection, MDD, Sore throat, History, Classification, Virus, Ill, MDR, Eurofins Scientific, Safety, Trypsin, Medical device

Eurofins, a European approved notified body for medical devices, has certified the ColdZyme® product line MDR (class III) according to the European Union medical device regulation.

Key Points: 
  • Eurofins, a European approved notified body for medical devices, has certified the ColdZyme® product line MDR (class III) according to the European Union medical device regulation.
  • MDR replaces the previous EU regulation MDD and imposes stricter requirements on evidence of clinical validity, safety design, and market surveillance.
  • ColdZyme is one of the first flu- and cold products to be certified under the new regulation.
  • "This certification process has meant extensive review of our quality processes and product data in accordance with the medical device legislation.

Herbal medicinal product: Verbasci flosArray, C: ongoing call for scientific data

Retrieved on: 
Wednesday, April 3, 2024
Verbascum, Patient, Monograph, Committee, Sore throat, Herbal medicine, Date, Plant, Agency, Flower, Medicine

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of mullein flower.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing mullein flower.
  • These mullein flower medicines may also be found in combination with other herbal substances in some herbal medicines.
  • Key facts
    - Latin name
    - Verbasci flos
    - English common name
    - Mullein Flower
    - Botanical name
    Verbascum thapsus L.; V. densiflorum Bertol.

Mucinex and TV Personality Nick Viall Celebrates New Product with Pop-Up Café Offering New Yorkers Free Coffee

Retrieved on: 
Monday, January 15, 2024
IQVIA, Congestion, Sore throat, New Yorker, Life, Kick start, Reckitt, Viall, Work, Coffee, Fever, Transport, Sensation, Marketing, Dietary supplement

PARSIPPANY, N.J., Jan. 15, 2024 /PRNewswire/ -- When you're suffering from cold and flu symptoms – whether it be a cough, congestion, sore throat, or fever – symptoms seem to feel worse when we first wake up. And if you're a busy person on the go, this can be especially disruptive to an already long day ahead.

Key Points: 
  • And if you're a busy person on the go, this can be especially disruptive to an already long day ahead.
  • "And when those disruptive cold and flu symptoms do hit, we always feel worse upon waking up.
  • Mucinex Kickstart provides powerful fast-acting multi-symptom relief and instant cooling sensation, giving consumers that morning kick to help them make a strong come back."
  • As part of this experience, New Yorkers will be treated to a complimentary cup of coffee, served by a fleet of baristas and award-winning podcast host, TV personality, and bestselling author Nick Viall the morning January 17th.

Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 6, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Medical Subject Headings, Marketing, Protein, Agency, Pharyngitis, INN, ATC, Urinary tract infection, International, Cough, Cystic fibrosis, Sore throat, Ageing, Language, Literature, Pseudomonas aeruginosa, Catherine Disher, Lower respiratory tract infection, European Medicines Agency, Infection, Fibrosis, Select, Patient, Bacteria, Anatomy, IIA, Periodic breathing, Medical device

Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 6, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Norvir, ritonavir, Date of authorisation: 25/08/1996, Revision: 70, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Liver, Medical Subject Headings, Peripheral neuropathy, Diarrhea, Marketing, Zidovudine, European Commission, Protease, Pharyngitis, INN, Immune system, Heartburn, HIV/AIDS, Fatigue, Saquinavir, Darunavir, ATC, Depression, Itch, Ritonavir, AIDS, International, Capsule, Cough, European, Headache, Disease, CD4, Ageing, Body surface area, Blood, Sore throat, Nausea, Rash, Language, Mouth, Abdominal pain, Dizziness, Flushing, Infection, Food, Indigestion, HIV, Tablet, Chronic pain, Reproduction, Back pain, Select, Committee, Patient, Dysgeusia, Risk management, Anatomy, Medicine, Paresthesia, Vomiting, IIA, Lopinavir, CHMP, Viral load, Vaccine

Human medicines European public assessment report (EPAR): Norvir, ritonavir, Date of authorisation: 25/08/1996, Revision: 70, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Norvir, ritonavir, Date of authorisation: 25/08/1996, Revision: 70, Status: Authorised

Lifestyle expert offers tips on how to have a happy, healthy holiday

Retrieved on: 
Wednesday, December 20, 2023
Mineral, Auburn University, Family, Travel, Fever, Immune system, Risk, Multimedia, Friends, Diarrhea, JD, Holiday, Diet, Fatigue, Headache, Sore throat, Nose, Health, Nausea, Nutrient, Brain, Mouth, College, Eating, Guilt, Exercise, Sneeze, Water, Food, Sleep, Germ, American College, Nurse education, Medicine, Vomiting, Cough, Nursing

DeBellis is an expert in the use of lifestyle changes, including eating patterns, physical activity, sleep and stress management, as preventative medicine and treatment for chronic conditions.

Key Points: 
  • DeBellis is an expert in the use of lifestyle changes, including eating patterns, physical activity, sleep and stress management, as preventative medicine and treatment for chronic conditions.
  • DeBellis holds a Doctor of Nursing Practice and is a certified professional of the American College of Lifestyle Medicine.
  • Ultimately, we want to practice healthy lifestyle choices year-round to improve our immune system and overall health.
  • These healthy lifestyle choices include getting regular exercise, following a micronutrient rich healthy eating plan, getting quality sleep, managing stress, improving social connections, quitting smoking and reducing our alcohol intake.

United States MAXIGESIC IV (Paracetamol + Ibuprofen) Drug Insights and Market Forecasts, 2019-2022 and 2023-2032 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 14, 2023
Health, Pharmaceutical, Headache, Research, Pain, Tennis elbow, Clinical trial, Migraine, Patient, Phenylephrine, SWOT, Arthritis, Sore throat, Myalgia, Ibuprofen, Gamer, Paracetamol, Chronic pain, Hospital, Fever, Common, Chemical oxygen demand, Toothache, Medical device, Poultry farming, Dietary supplement, Pharmaceutical industry

The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights about MAXIGESIC IV for acute pain in the United States.
  • A detailed picture of the MAXIGESIC IV for acute pain in the United States for the study period 2019 -2032 is provided in this report along with a detailed description of the MAXIGESIC IV for acute pain.
  • This report provides a detailed market assessment of MAXIGESIC IV for acute pain in the United States.

The Inner Circle Acknowledges, Reginald D. Hughes as a Top Pinnacle Healthcare Professional for his contributions to the field of Family Medicine

Retrieved on: 
Friday, December 8, 2023
Inner circle, School, American Public University System, American Astronomical Society, Operation Crossroads, Family medicine, University, STD, Astronomy, Fever, American Academy, Patient, Jamaica Hospital Medical Center, Multimedia, Sore throat, Chemical engineering, MPH, NGO, FAAFP, Family, United States Army Reserve, White Plains Hospital, American Public Health Association, Master, Public, Nursing, Medicine, MD, COVID

LAURELTON, N.Y., Dec. 8, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Reginald D. Hughes, MD, MPH, FAAFP, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Family Medicine.

Key Points: 
  • LAURELTON, N.Y., Dec. 8, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Reginald D. Hughes, MD, MPH, FAAFP, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Family Medicine.
  • He completed a residency in family medicine and a fellowship in family medicine/obstetrics, both completed at Jamaica Hospital Medical Center in Queens, NY from 1998 to 2001.
  • The doctor also holds an MPH (public health) and a Master's degree in space studies (astronomy) from the American Military University.
  • The doctor noted that family medicine is a medical specialty devoted to comprehensive health care for people of all ages.